Roche Pharma CEO Bill Anderson to step down

Anderson will be replaced on a temporary basis by Thomas Schinecker, the current head of diagnostics who is due to become group CEO on March 14.

Published On 2022-12-12 10:00 GMT   |   Update On 2022-12-12 10:00 GMT

Zurich: Roche's head of its pharmaceuticals division will leave the drugmaker at the end of the year, the Swiss company said on Monday, as it confirmed other parts of its succession plan.Former Genentech boss Bill Anderson "has decided to pursue opportunities outside of Roche," Roche said, with a successor due to be named by March 2023.Anderson will be replaced on a temporary basis by...

Login or Register to read the full article

Zurich: Roche's head of its pharmaceuticals division will leave the drugmaker at the end of the year, the Swiss company said on Monday, as it confirmed other parts of its succession plan.

Former Genentech boss Bill Anderson "has decided to pursue opportunities outside of Roche," Roche said, with a successor due to be named by March 2023.

Anderson will be replaced on a temporary basis by Thomas Schinecker, the current head of diagnostics who is due to become group CEO on March 14.

Schinecker will replace Severin Schwan, who is slated to become chairman after 14 years as CEO of Roche.

"Over his 16-year career at Roche, Bill Anderson has demonstrated excellent leadership. He has been instrumental in shaping Roche's transformation and I wish him all the best for the future," Schwan said in a statement.

Anderson joined California-based Genentech in 2006 as senior vice president of the Immunology and Ophthalmology Business Unit, before leading the Bio oncology Business Unit.

He had been CEO of Roche's pharmaceuticals business since 2019.

In proposals for next year's AGM, Roche also confirmed its intention to propose Schwan as the next chairman.

As previously announced in July 2022, Christoph Franz has decided not to seek re-election as chairman, Roche said on Monday.

Read also: Roche Diagnostics Middle East secures ISO27001 Information Security certification

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News